{"id":5577,"date":"2006-03-26T00:20:36","date_gmt":"2006-03-25T23:20:36","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=5577"},"modified":"2013-12-07T07:45:37","modified_gmt":"2013-12-07T07:45:37","slug":"13th-conference-on-retroviruses-and-opportunistic-infections-croi-5-8-february-2006-denver","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/5577","title":{"rendered":"13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver"},"content":{"rendered":"<p><strong><a href=\"https:\/\/i-base.info\/htb\/keyword\/croi-2006\">Reports from the conference<\/a> <\/strong><\/p>\n<p><strong>This year CROI was generally an optimistic conference, with studies on new drugs, a few news studies on side effects and lipodystrophy, and a range of other interesting smaller studies. The presentation of the SMART study provided sufficient new data to restart discussions on treatment interruptions, large-scale research, and by implications, the optimal timing for initial treatment.<\/strong><\/p>\n<p>CROI also provides some of the best online support for people unable to attend the meeting. Abstracts are online already, and are searchable by subject or author. Webcasts are routinely provided of the plenary talks, and this year for the first time, are also provided for the most important oral scientific presentations. These online presentations, including slides, can also me downloaded as mp3 audio files or podcasts.<\/p>\n<p>The 13th Conference on Retroviruses and Opportunistic Infections <a href=\"http:\/\/www.retroconference.org\"><span>http:\/\/www.retroconference.org <\/span><\/a><\/p>\n<p>Reports in this issue of HTB from CROI include:<\/p>\n<ul>\n<li><a title=\"Permanent link to Early integrase inhibitor studies in treatment experienced patients raise hopes for new drugs in a new class\" href=\"https:\/\/i-base.info\/htb\/2796\" rel=\"bookmark\">Early integrase inhibitor studies in treatment experienced patients raise hopes for new drugs in a new class<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Atazanavir in treatment naive patients, with and without ritonavir boosting\" href=\"https:\/\/i-base.info\/htb\/5683\" rel=\"bookmark\">Atazanavir in treatment naive patients, with and without ritonavir boosting<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Simplification to atazanavir\/ritonavir monotherapy\" href=\"https:\/\/i-base.info\/htb\/5686\" rel=\"bookmark\">Simplification to atazanavir\/ritonavir monotherapy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Summary of STI studies: SMART shows clear increased risk from interrupting treatment at any CD4 count\" href=\"https:\/\/i-base.info\/htb\/5679\" rel=\"bookmark\">Summary of STI studies: SMART shows clear increased risk from interrupting treatment at any CD4 count<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to The effect of repeated single-dose nevirapine for PMTCT in a second pregnancy\" href=\"https:\/\/i-base.info\/htb\/5676\" rel=\"bookmark\">The effect of repeated single-dose nevirapine for PMTCT in a second pregnancy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Should criteria for initiation of HAART be revisited in pregnant women?\" href=\"https:\/\/i-base.info\/htb\/5674\" rel=\"bookmark\">Should criteria for initiation of HAART be revisited in pregnant women?<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Cotrimoxazole prophylaxis in pregnancy\" href=\"https:\/\/i-base.info\/htb\/5671\" rel=\"bookmark\">Cotrimoxazole prophylaxis in pregnancy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Treatment in primary HIV infection\" href=\"https:\/\/i-base.info\/htb\/5669\" rel=\"bookmark\">Treatment in primary HIV infection<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to CNS penetration of ARV drugs is associated with lower CSF viral load\" href=\"https:\/\/i-base.info\/htb\/5664\" rel=\"bookmark\">CNS penetration of ARV drugs is associated with lower CSF viral load<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Sexual transmission of hepatitis C in HIV-positive men in the UK\" href=\"https:\/\/i-base.info\/htb\/5661\" rel=\"bookmark\">Sexual transmission of hepatitis C in HIV-positive men in the UK<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to D:A:D study shows that PIs rather than NNRTIs drive the previously reported cardiovascular risk of combination antiretroviral therapy\" href=\"https:\/\/i-base.info\/htb\/5659\" rel=\"bookmark\">D:A:D study shows that PIs rather than NNRTIs drive the previously reported cardiovascular risk of combination antiretroviral therapy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Interventions for the management of lipodystrophy and metabolic complications\" href=\"https:\/\/i-base.info\/htb\/3011\" rel=\"bookmark\">Interventions for the management of lipodystrophy and metabolic complications<\/a><\/li>\n<\/ul>\n<p>Further reports from CROI will also be included in the <a href=\"https:\/\/i-base.info\/htb\/date\/2006\/04\">April<\/a> and <a href=\"https:\/\/i-base.info\/htb\/date\/2006\/05\">May<\/a> issues of HTB.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reports from the conference This year CROI was generally an optimistic conference, with studies on new drugs, a few news studies on side effects and lipodystrophy, and a range of other interesting smaller studies. The presentation of the SMART study &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,60],"class_list":["post-5577","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-croi-2006"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/5577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=5577"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/5577\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=5577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=5577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=5577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}